FDA Inspection 754912 — Intermax Pharmaceuticals, Inc.

Intermax Pharmaceuticals, Inc. — FEI 3002729102

The FDA completed an inspection of Intermax Pharmaceuticals, Inc. on November 28, 2011 in Farmingdale, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 28, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmingdale, NY (United States)